[Latest Findings on the Role of CD47 in Tumor Immune Evasion and Related Targeted Therapies].

Jie, Xiao-Liang; Kong, Yang-Yang; Zhou, Guang-Biao

Jie, Xiao-Liang; Kong, Yang-Yang; Zhou, Guang-Biao.

Affiliation

Jie XL; State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China.
Kong YY; State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China.
Zhou GB; State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China.

Sichuan Da Xue Xue Bao Yi Xue Ban ; 54(3): 455-461, 2023 May.

Article in Zh | MEDLINE | ID: mdl-37248568

Subject(s)

Antineoplastic Agents; CD47 Antigen; Neoplasms; Humans; Antibodies, Monoclonal/therapeutic use; Antineoplastic Agents/therapeutic use; CD47 Antigen/metabolism; Immunotherapy; Macrophages/metabolism; Neoplasms/drug therapy; Phagocytosis; Tumor Escape

Key words

CD47; Immunotherapy; SIRPα; Tumor

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD47 Antigen / Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: Zh Journal: Sichuan Da Xue Xue Bao Yi Xue Ban Year: 2023 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google